Internal Medicine, Infectious Disease · Brandon, FL
NPI
1184667198
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
214 Morrison Rd, Suite 104
Brandon, FL, 33511
Phone (813) 681-6474
Groups this clinician bills Medicare through
Medicare paid, 2024
$466K
136,875 services
Medicare patients, 2024
518
Average age 75
Drug cost, 2024
$2.0M
820 prescriptions
Company payments, 2025
$2,125
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose E Vasquez was code J2407 (injection, oritavancin (orbactiv), 10 mg), 2,160 times for 16 patients. In total Jose E Vasquez billed 136,875 services in 69 codes, and Medicare paid $466K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2407 Injection, oritavancin (orbactiv), 10 mg | Office | 2,160 | 16 | $21.76 | $47K |
| J0897 Injection, denosumab, 1 mg | Office | 1,320 | 13 | $20.62 | $27K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 1,060 | 57 | $0.49 | $517 |
| 96365 Intravenous Infusion, Hydration | Office | 840 | 56 | $46.55 | $39K |
| 99232 Hospital E&M - Subsequent | Facility | 646 | 267 | $61.08 | $39K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 453 | 16 | $9.07 | $4,111 |
| 99214 Office E&M - Established | Office | 267 | 107 | $91.94 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 190 | 117 | $90.67 | $17K |
| 99223 Hospital E&M - Initial | Facility | 113 | 112 | $131.65 | $15K |
| 99222 Hospital E&M - Initial | Facility | 108 | 102 | $98.26 | $11K |
| 99231 Hospital E&M - Subsequent | Facility | 105 | 56 | $38.86 | $4,080 |
| 96367 Intravenous Infusion, Hydration | Office | 103 | 11 | $21.29 | $2,192 |
| 99215 Office E&M - Established | Office | 85 | 57 | $129.81 | $11K |
| 96413 Chemotherapy Administration | Office | 70 | 16 | $94.91 | $6,643 |
| 96366 Intravenous Infusion, Hydration | Office | 49 | 12 | $15.37 | $753 |
By year: 2022 $177K for 4,361 services; 2023 $355K for 94,203 services; 2024 $466K for 136,875 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 43 | 19 | $8.65 | $372 |
Medicare prescription drug claims, 2024
In 2024, the drug Jose E Vasquez prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 88 prescriptions and refills. In total Jose E Vasquez wrote 820 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 88 | 88 | 16 | $352K |
| Azithromycin Generic | 59 | 87 | 17 | $1,744 |
| Ethambutol Hcl Generic | 51 | 61 | 13 | $2,402 |
| Rifabutin Generic | 39 | 46 | Under 11 | $21K |
| Meropenem Generic | 29 | 29 | 17 | $3,691 |
| Ceftriaxone Ceftriaxone Sodium | 28 | 28 | Under 11 | $1,191 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 23 | 23 | Under 11 | $267K |
| Rifampin Generic | 21 | 33 | Under 11 | $1,120 |
| Tivicay Dolutegravir Sodium | 21 | 21 | Under 11 | $45K |
| Cefdinir Generic | 20 | 31 | 13 | $354 |
| Vancomycin Hcl Generic | 19 | 27 | 11 | $3,395 |
| Cefepime Hcl Generic | 19 | 19 | Under 11 | $2,670 |
| Ertapenem Ertapenem Sodium | 18 | 18 | Under 11 | $11K |
| Dovato Dolutegravir Sodium/Lamivudine | 17 | 17 | Under 11 | $49K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 16 | 16 | Under 11 | $66K |
Brand drugs: 334 claims; generic drugs: 486 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose E Vasquez $2,125 ($2,125 in general payments such as food, travel and fees) from 15 companies. The largest payer was ViiV Healthcare Company with $360.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 13 | $360 |
| Melinta Therapeutics, LLC | 10 | $340 |
| Abbvie Inc. ABBV | 11 | $259 |
| Insmed, Inc. INSM | 12 | $256 |
| Aimmune Therapeutics, Inc. | 12 | $203 |
| Astellas Pharma US Inc 4503.T | 3 | $156 |
| Merck Sharp & Dohme LLC MRK | 6 | $145 |
| Shionogi Inc 4507.T | 4 | $79.05 |
| Gilead Sciences, Inc. GILD | 3 | $76.83 |
| Electromed, Inc. ELMD | 4 | $57.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.